Wednesday - October 29, 2025
Yale Study Sheds Light on Cellular Resistance to Osimertinib in Adenocarcinoma
October 24, 2025
NEW HAVEN, Connecticut, Oct. 24 (TNSjou) -- The Yale University School of Medicine issued the following news:

* * *

Yale Study Sheds Light on Cellular Resistance to Osimertinib in Adenocarcinoma

Protein METTL7A plays key role in resistance to drugs targeting EGFR-mutant lung adenocarcinoma

By Naedine Hazell

Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now dis . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products